James Rucks, Regional Sales Manager, GenPath Diagnostics / BioReference Laboratories talks about the Opco “4Kscore” which is the only test to assess a patient’s risk for aggressive prostate cancer prior to a prostate biopsy.
Is there a better way to keep finding prostate cancer but not over diagnose? A solution is more intelligent testing, It needs better specificity and it needs to separate high grade cases from low grade cases. The 4Kscore® Test is the only blood test that accurately identifies an individual’s risk for aggressive
prostate cancer. It predicts aggressive prostate cancer.
This is a must have DVD if you're tinking about a biopsy.